DISSOLUTION IMPROVEMENT OF KETOPROFEN THROUGH POLYMER MATRIX COMPOSITE POVIDONE K-30/TiO2

Aliyah; Eka Tri  Saputri; Diana  Fitriah; Andi  Arjuna

doi:10.18006/2021.9(Spl-2-ICOPMES_2020).S234.S240

Authors

Aliyah Pharmaceutics, Faculty of Pharmacy, Hasanuddin University, Jl. Perintis Kemerdekaan No.10, Makassar, Sulawesi Selatan, 90245, Indonesia
Eka Tri Saputri Pharmaceutics, Faculty of Pharmacy, Hasanuddin University, Jl. Perintis Kemerdekaan No.10, Makassar, Sulawesi Selatan, 90245, Indonesia
Diana Fitriah Pharmaceutics, Faculty of Pharmacy, Hasanuddin University, Jl. Perintis Kemerdekaan No.10, Makassar, Sulawesi Selatan, 90245, Indonesia
Andi Arjuna Pharmaceutics, Faculty of Pharmacy, Hasanuddin University, Jl. Perintis Kemerdekaan No.10, Makassar, Sulawesi Selatan, 90245, Indonesia

DOI:

https://doi.org/10.18006/2021.9(Spl-2-ICOPMES_2020).S234.S240

Keywords:

Dissolution profile, Ketoprofen, Polymer matrix composite, Povidone K30, TiO2

Abstract

Ketoprofen is a nonsteroidal anti-inflammatory drug that has been classified into Class II as per the Biopharmaceutics Classification System. This substance has low solubility i.e. only 51 mg/L at 22℃. Therefore, a study of ketoprofen modification prepared in Polymer Matrix Composite (PMC) using Povidone K-30, coated with TiO2 as an effort to improve its dissolution profile, had been conducted. Composite particles were prepared through a dissolving method with a ratio of ketoprofen: Povidone K30 i.e. 1: 1 (F1), 1: 2 (F2), and 1: 4 (F3). They were evaluated and continued on the coating process using TiO2 30%, 40%, and 50%. Results of the study revealed that the PMC provides an absence of chemical intervention against ketoprofen. All the used combination ratios improved the dissolution profile by using phosphate buffer media pH 7.5 for 60 minutes. After coating, a release profile was obtained by running it on phosphate buffer media at pH 6.8 for 8 hours, this showing a sustained release profile.

References

Bazzo GC, Lemos-Senna E, Pires ATN (2009) Poly (3-hydroxybutyrate)/chitosan/ketoprofen or piroxicam composite microparticles: preparation and controlled drug release evaluation. Carbohydrate Polymers 77(4): 839–844.

Dang ZM, Yuan JK, Zha JW, Sheng TZ, HualHu TG (2012) Fundamentals, processes and applications of high-permittivity polymer–matrix composites. Progress in materials science 57(4): 660–723.

Franco P, De Marco I (2020) The Use of Poly (N-vinyl pyrrolidone) in the Delivery of Drugs: A Review. Polymers 12(5): 1114.

Frizon F, de Oliveira Eloya J, Donaduzzib CM, Mitsuib ML, Marchettia JM (2013) Dissolution rate enhancement of loratadine in polyvinylpyrrolidone K-30 solid dispersions by solvent methods. Powder Technology 235: 532–539.

Grimling B, Górniak A, Meler J, Szcześniak M (2014) Characterisation and dissolution properties of ketoprofen In binary solid dispersion with chitosan. Progress on Chemistry and Application of Chitin and its Derivatives 19: 23–31.

Himawan A, Djide NJN, Mudjahid M, Lukita ADI, Arjuna A, Aliyah (2019) ‘Physicochemical and Micromeritics Properties of Ketoprofen-Tartaric Acid Binary System. Journal of Physics: Conference Series IOP Publishing, 1341(7): 72004.

Holowka EP, Bhatia SK (2014) Controlled-release systems. Drug delivery. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1998-7_2.

Ibrahim MA, Amin MA, Fetih G, Abou Ela A (2010) Formulation and evaluation of ketorolac tromethamine-Eudragit solid dispersions of potential sustained-release properties. STP Pharma Pratiques 20(3): 189.

Kamari Y, Ghiaci M (2016) Preparation and characterization of ibuprofen/modified chitosan/TiO2 hybrid composite as a controlled drug-delivery system. Microporous and Mesoporous Materials 234: 361–369.

Kazarian SG, Martirosyan GG (2002) Spectroscopy of polymer/drug formulations processed with supercritical fluids: in situ ATR–IR and Raman study of impregnation of ibuprofen into PVP. International Journal of Pharmaceutics 232(1–2): 81–90.

Mircioiu C, Voicu V, Anuta V, Tudose A, Celia C, Paolino D, Fresta M, Sandulovici R, Mircioiu I (2019) Mathematical modeling of release kinetics from supramolecular drug delivery systems. Pharmaceutics 11(3): 140.

Mohammadian M, Kashi TSJ, Erfan M, Soorbaghid FP (2018) In-vitro study of Ketoprofen release from synthesized silica aerogels (as drug carriers) and evaluation of mathematical kinetic release models. Iranian Journal of Pharmaceutical Research 17(3): 818.

Rençber S, Karavana SY, Özyazici M (2009) Bioavailability file: ketoprofen. FABAD Journal of Pharmaceutical Sciences 34(4): 203.

Sabzi M, Mirabedini SM, Zohuriaan-Mehr J, Atai M (2009) Surface modification of TiO2 nano-particles with silane coupling agent and investigation of its effect on the properties of polyurethane composite coating. Progress in Organic Coatings 65(2): 222–228.

Saffoon N, Uddin R, Huda NH, Sutradhar KB (2011) Enhancement of oral bioavailability and solid dispersion: a review. Journal of Applied Pharmaceutical Science 1(7):13-20.

Schumacher Jr, HR (1994) Ketoprofen extended-release capsules: a new formulation for the treatment of osteoarthritis and rheumatoid arthritis. Clinical Therapeutics 16(2): 145–159.

Shohin IE, Kulinich JI, Ramenskaya GV, Abrahamsson B, Kopp S, Langguth P, et al. (2012) Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen. Journal of Pharmaceutical Sciences 101(10): 3593–3603.

Teti R (2002) Machining of composite materials. CIRP Annals 51(2): 611–634.

USP-NF (2018) The United States Pharmacopeia and the National Formulary. The United States Pharmacopeial Convention.

Wang RM, Zheng SR, Zheng YG (2011) Polymer matrix composites and technology. Elsevier Publication.